Glioma epidemiology and demographics: Difference between revisions
No edit summary |
Mahshid |
||
(9 intermediate revisions by one other user not shown) | |||
Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
Glioma is the common primary intracranial tumor. The incidence of glioma is estimated to be 4.9 cases per 100,000 individuals in the US | Glioma is the most common primary [[brain tumor|intracranial tumor]]. The [[incidence]] of glioma is estimated to be 4.9 cases per 100,000 individuals in the US.<ref name="pmid16932614">{{cite journal| author=Schwartzbaum JA, Fisher JL, Aldape KD, Wrensch M| title=Epidemiology and molecular pathology of glioma. | journal=Nat Clin Pract Neurol | year= 2006 | volume= 2 | issue= 9 | pages= 494-503; quiz 1 p following 516 | pmid=16932614 | doi=10.1038/ncpneuro0289 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16932614 }} </ref> Patients of all age groups may develop glioma. Males are more commonly affected with glioma than females. It usually affects individuals of the caucasian race. African american, latin american, and asian individuals are less likely to develop glioma. | ||
==Epidemiology and demographics== | ==Epidemiology and demographics== | ||
===Incidence=== | ===Incidence=== | ||
*Glioma is the common primary intracranial tumor. | *Glioma is the most common primary [[brain tumor|intracranial tumor]]. | ||
*The incidence of glioma is estimated to be 4.9 cases per 100,000 individuals in the US.<ref name="pmid16932614">{{cite journal| author=Schwartzbaum JA, Fisher JL, Aldape KD, Wrensch M| title=Epidemiology and molecular pathology of glioma. | journal=Nat Clin Pract Neurol | year= 2006 | volume= 2 | issue= 9 | pages= 494-503; quiz 1 p following 516 | pmid=16932614 | doi=10.1038/ncpneuro0289 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16932614 }} </ref> | *The [[incidence]] of glioma is estimated to be 4.9 cases per 100,000 individuals in the US.<ref name="pmid16932614">{{cite journal| author=Schwartzbaum JA, Fisher JL, Aldape KD, Wrensch M| title=Epidemiology and molecular pathology of glioma. | journal=Nat Clin Pract Neurol | year= 2006 | volume= 2 | issue= 9 | pages= 494-503; quiz 1 p following 516 | pmid=16932614 | doi=10.1038/ncpneuro0289 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16932614 }} </ref> | ||
===Age=== | |||
*Patients of all age groups may develop glioma. | |||
*[[Pilocytic astrocytoma]] is a common disease that tends to affect children and adolescents. The median age at diagnosis is 17 years. | |||
*[[Glioblastoma multiforme]] is a common disease that tends to affect the elderly population. The median age at diagnosis is 62 years. | |||
===Gender=== | ===Gender=== | ||
Males are more commonly affected with glioma than females.<ref name="pmid16932614">{{cite journal| author=Schwartzbaum JA, Fisher JL, Aldape KD, Wrensch M| title=Epidemiology and molecular pathology of glioma. | journal=Nat Clin Pract Neurol | year= 2006 | volume= 2 | issue= 9 | pages= 494-503; quiz 1 p following 516 | pmid=16932614 | doi=10.1038/ncpneuro0289 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16932614 }} </ref> | *Males are more commonly affected with glioma than females.<ref name="pmid16932614">{{cite journal| author=Schwartzbaum JA, Fisher JL, Aldape KD, Wrensch M| title=Epidemiology and molecular pathology of glioma. | journal=Nat Clin Pract Neurol | year= 2006 | volume= 2 | issue= 9 | pages= 494-503; quiz 1 p following 516 | pmid=16932614 | doi=10.1038/ncpneuro0289 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16932614 }} </ref> | ||
===Race=== | ===Race=== | ||
Glioma usually affects individuals of the caucasian race. African american, latin american, and asian individuals are less likely to develop glioma. | *Glioma usually affects individuals of the caucasian race. African american, latin american, and asian individuals are less likely to develop glioma. | ||
==References== | ==References== | ||
Line 29: | Line 34: | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Neurology]] | |||
[[Category:Neurosurgery]] |
Latest revision as of 23:37, 26 November 2017
Glioma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Glioma epidemiology and demographics On the Web |
American Roentgen Ray Society Images of Glioma epidemiology and demographics |
Risk calculators and risk factors for Glioma epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2]
Overview
Glioma is the most common primary intracranial tumor. The incidence of glioma is estimated to be 4.9 cases per 100,000 individuals in the US.[1] Patients of all age groups may develop glioma. Males are more commonly affected with glioma than females. It usually affects individuals of the caucasian race. African american, latin american, and asian individuals are less likely to develop glioma.
Epidemiology and demographics
Incidence
- Glioma is the most common primary intracranial tumor.
- The incidence of glioma is estimated to be 4.9 cases per 100,000 individuals in the US.[1]
Age
- Patients of all age groups may develop glioma.
- Pilocytic astrocytoma is a common disease that tends to affect children and adolescents. The median age at diagnosis is 17 years.
- Glioblastoma multiforme is a common disease that tends to affect the elderly population. The median age at diagnosis is 62 years.
Gender
- Males are more commonly affected with glioma than females.[1]
Race
- Glioma usually affects individuals of the caucasian race. African american, latin american, and asian individuals are less likely to develop glioma.
References
- ↑ 1.0 1.1 1.2 Schwartzbaum JA, Fisher JL, Aldape KD, Wrensch M (2006). "Epidemiology and molecular pathology of glioma". Nat Clin Pract Neurol. 2 (9): 494–503, quiz 1 p following 516. doi:10.1038/ncpneuro0289. PMID 16932614.